US Patent 7511123 Immuno-interactive fragments of the alpha-C subunit of inhibin

Patent 7511123 was granted and assigned to Prince Henry's Institute of Medical Research on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Prince Henry's Institute of Medical Research

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75111230

Patent Inventor Names

Peter Gordon Stanton0

David Mark Milne-Robertson0

Nicholas Francis Cahir0

Date of Patent

March 31, 2009

Patent Application Number

101251870

Date Filed

April 18, 2002

Patent Primary Examiner

‌

Mark L. Shibuya

Patent abstract

Novels immuno-interactive fragments of the (alpha)C portion of a mammalian inhibin alpha subunit are disclosed, together with their variants and derivatives for producing antigen-binding molecules that are interactive with said (alpha)C portion, which are chemically well defined and which can be produced in commercially significant quantities. The antigen-binding molecules of the invention can be used for the detection of a mammalian inhibin and for the treatment and/or prevention of conditions associated with aberrant levels of a mammalian inhibin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7511123 Immuno-interactive fragments of the alpha-C subunit of inhibin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API